论文部分内容阅读
目的:对应用中药肺积饮与~(125)I粒子植入方式联合对病情处于晚期阶段的非小细胞肺癌患者实施治疗的临床效果进行研究。方法:选择本院收治的病情处于晚期阶段的非小细胞肺癌患者86例,随机分为对照组和观察组,平均每组43例。采用单纯125I粒子植入技术对对照组患者实施治疗;采用中药肺积饮与125I粒子植入方式联合对观察组患者实施治疗。结果:观察组患者在治疗期间出现的相关不良反应人数明显少于对照组(P<0.05);肺癌症状控制时间和肺癌治疗计划实施总时间明显短于对照组(P<0.05);晚期非小细胞肺癌治疗效果明显优于对照组(P<0.05)。结论:应用中药肺积饮与~(125)I粒子植入方式联合对病情处于晚期阶段的非小细胞肺癌患者实施治疗的临床效果非常明显。
OBJECTIVE: To study the clinical effects of using traditional Chinese medicine Pianji Yin and ~ (125) I seed implantation in the treatment of non-small cell lung cancer patients in advanced stage. Methods: A total of 86 patients with non-small cell lung cancer who were admitted to our hospital for advanced stage were randomly divided into control group and observation group, with an average of 43 cases in each group. The patients in the control group were treated with pure 125I seed implantation technique. The patients in the observation group were treated with the combination of Plum Plum drink and 125I seed implantation. Results: The number of adverse reactions in the observation group was significantly less than that in the control group (P <0.05). The control time of lung cancer and the total duration of treatment for lung cancer were significantly shorter in the observation group than in the control group (P <0.05) The therapeutic effect of cell lung cancer was better than that of the control group (P <0.05). Conclusion: The clinical effect of using Plum-Yin and ~ (125) I seed implantation combined with traditional Chinese medicine in the treatment of advanced non-small cell lung cancer is very obvious.